NCT00051948已完成1 期
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Telik12 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2003年1月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
- 试验地点
- 12
研究概览
简要总结
This is a dose-ranging, open label, Phase 1-2a study of TLK286 in combination with Paraplatin (carboplatin) in patients with recurrent ovarian cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Histologically or cytologically confirmed diagnosis of epithelial cancer of the ovary, fallopian tube, or primary peritoneal cancer
- •Recurrent ovarian cancer or persistent disease following primary treatment
- •At least one, but no more than four, prior chemotherapy regimens (all platinum-containing counted as one)
- •At least 18 years of age
排除标准
- •Pregnant or lactating women
- •History of prior malignancy except for adequately treated carcinoma in situ of the uterine cervix, basal cell or squamous cell skin cancer, or other cancer for which patient has been disease-free for at least 2 years
- •Known leptomeningeal metastases or carcinomatous meningitis
- •Having received whole pelvis radiation therapy
研究者
研究点 (12)
Loading locations...
相似试验
已完成
3 期
TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian CancerOvarian NeoplasmsNCT00102973Telik244
已完成
1 期
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung CancerCarcinoma, Non-small-cell LungNCT00047801Telik28
已完成
1 期
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Non-small Cell Lung CancerNCT00077883Telik50
已完成
1 期
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian CancerOvarian NeoplasmsNCT00052065Telik28
已完成
2 期
Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian CancerOvarian NeoplasmsNCT00038428Telik40